NOTARFRANCHI, LAURA
NOTARFRANCHI, LAURA
Dipartimento di Medicina e Chirurgia
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma
2020-01-01 Manzoni, M.; Marchica, V.; Storti, P.; Ziccheddu, B.; Sammarelli, G.; Todaro, G.; Pelizzoni, F.; Salerio, S.; Notarfranchi, L.; Pompa, A.; Baldini, L.; Bolli, N.; Neri, A.; Giuliani, N.; Lionetti, M.
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients
2020-01-01 Dalla Palma, B.; Accardi, F.; Prezioso, L.; Notarfranchi, L.; Giuliani, N.
Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link?
2021-01-01 Notarfranchi, L.; Marchica, V.; Dalla Palma, B.; Pelagatti, L.; Burroughs-Garcia, J.; Pedrazzoni, M.; Ruffini, L.; Cetani, F.; Marcocci, C.; Giuliani, N.
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response
2022-01-01 Storti, Paola; Marchica, Valentina; Vescovini, Rosanna; Franceschi, Valentina; Russo, Luca; Notarfranchi, Laura; Raimondi, Vincenzo; Toscani, Denise; Burroughs Garcia, Jessica; Costa, Federica; Dalla Palma, Benedetta; Iannozzi, Nicolas Thomas; Sammarelli, Gabriella; Donofrio, Gaetano; Giuliani, Nicola
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA
2018-01-01 Pagliaro, L; Sammarelli, G; Russo, F; Plenteda, C; Todaro, G; Pelagatti, L; Notarfranchi, L; Falcioni, F; Aversa, F; Re, F
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
2021-01-01 Romano, A.; Storti, P.; Marchica, V.; Scandura, G.; Notarfranchi, L.; Craviotto, L.; Di Raimondo, F.; Giuliani, N.
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients
2021-01-01 Costa, F.; Vescovini, R.; Marchica, V.; Storti, P.; Notarfranchi, L.; Dalla Palma, B.; Toscani, D.; Burroughs-Garcia, J.; Catarozzo, M. T.; Sammarelli, G.; Giuliani, N.
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results
2021-01-01 Fazzi, R.; Petrini, I.; Giuliani, N.; Morganti, R.; Carulli, G.; Dalla Palma, B.; Notarfranchi, L.; Galimberti, S.; Buda, G.
The impact of CD56 expression in smoldering myeloma patients on early progression
2022-01-01 Notarfranchi, Laura; Segreto, Roberta; Vescovini, Rosanna; Dalla Palma, Anna Benedetta; Marchica, Valentina; Burroughs-Garcia, Jessica; Toscani, Denise; Todaro, Giannalisa; Raimondi, Vincenzo; Iannozzi, Nicolas Thomas; Bonomini, Sabrina; Sammarelli, Gabriella; Craviotto, Luisa; Pedrazzoni, Mario; Storti, Paola; Giuliani, Nicola
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma | 1-gen-2020 | Manzoni, M.; Marchica, V.; Storti, P.; Ziccheddu, B.; Sammarelli, G.; Todaro, G.; Pelizzoni, F.; Salerio, S.; Notarfranchi, L.; Pompa, A.; Baldini, L.; Bolli, N.; Neri, A.; Giuliani, N.; Lionetti, M. | |
| Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients | 1-gen-2020 | Dalla Palma, B.; Accardi, F.; Prezioso, L.; Notarfranchi, L.; Giuliani, N. | |
| Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link? | 1-gen-2021 | Notarfranchi, L.; Marchica, V.; Dalla Palma, B.; Pelagatti, L.; Burroughs-Garcia, J.; Pedrazzoni, M.; Ruffini, L.; Cetani, F.; Marcocci, C.; Giuliani, N. | |
| Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response | 1-gen-2022 | Storti, Paola; Marchica, Valentina; Vescovini, Rosanna; Franceschi, Valentina; Russo, Luca; Notarfranchi, Laura; Raimondi, Vincenzo; Toscani, Denise; Burroughs Garcia, Jessica; Costa, Federica; Dalla Palma, Benedetta; Iannozzi, Nicolas Thomas; Sammarelli, Gabriella; Donofrio, Gaetano; Giuliani, Nicola | |
| IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA | 1-gen-2018 | Pagliaro, L; Sammarelli, G; Russo, F; Plenteda, C; Todaro, G; Pelagatti, L; Notarfranchi, L; Falcioni, F; Aversa, F; Re, F | |
| Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma | 1-gen-2021 | Romano, A.; Storti, P.; Marchica, V.; Scandura, G.; Notarfranchi, L.; Craviotto, L.; Di Raimondo, F.; Giuliani, N. | |
| PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients | 1-gen-2021 | Costa, F.; Vescovini, R.; Marchica, V.; Storti, P.; Notarfranchi, L.; Dalla Palma, B.; Toscani, D.; Burroughs-Garcia, J.; Catarozzo, M. T.; Sammarelli, G.; Giuliani, N. | |
| Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results | 1-gen-2021 | Fazzi, R.; Petrini, I.; Giuliani, N.; Morganti, R.; Carulli, G.; Dalla Palma, B.; Notarfranchi, L.; Galimberti, S.; Buda, G. | |
| The impact of CD56 expression in smoldering myeloma patients on early progression | 1-gen-2022 | Notarfranchi, Laura; Segreto, Roberta; Vescovini, Rosanna; Dalla Palma, Anna Benedetta; Marchica, Valentina; Burroughs-Garcia, Jessica; Toscani, Denise; Todaro, Giannalisa; Raimondi, Vincenzo; Iannozzi, Nicolas Thomas; Bonomini, Sabrina; Sammarelli, Gabriella; Craviotto, Luisa; Pedrazzoni, Mario; Storti, Paola; Giuliani, Nicola |